Assessment of right ventricular metabolism: An emerging tool for monitoring pulmonary artery hypertension
- PMID: 27864729
- PMCID: PMC5505806
- DOI: 10.1007/s12350-016-0695-9
Assessment of right ventricular metabolism: An emerging tool for monitoring pulmonary artery hypertension
Comment on
-
Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension.J Nucl Cardiol. 2017 Dec;24(6):1979-1989. doi: 10.1007/s12350-016-0663-4. Epub 2016 Sep 29. J Nucl Cardiol. 2017. PMID: 27688036
References
-
- Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122:156–63. - PubMed
-
- Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al. Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL) Circulation. 2010;122:164–72. - PubMed
-
- Sandoval J, Bauerle O, Palomar A, Gomez A, Martinez-Guerra ML, Beltran M, et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation. 1994;89:1733–44. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical